Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate ...

A drug that targets two parts of the deadly Nipah virus protects against infection in hamsters. And once an animal is ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Fintel reports that on July 11, 2025, Raymond James initiated coverage of Vir Biotechnology (NasdaqGS:VIR) with a Outperform ...

As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.

New research has suggested that a virus that has typically been thought of as common and harmless may actually be associnrwd with an in creased risk of Par | Cell And Molecular Biology ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Researchers have developed the downstream section of a new streamlined production method for an emerging virus class.

As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds - ticks.

Today announced a strategic update highlighting its compelling clinical data from two tumor types and outlining a sharpened focus on advancing pelareorep, the Company's intravenously delivered ...